Browsing: BioVaxys

BioVaxys Technology Corp. will present its latest developments at the Emerging Growth Conference.

BioVaxys Technology Corp. (BIOV) has received a management cease trade order from the British Columbia Securities Commission following delays in its audited annual financial statements. The company expects to complete the filings by March 30, 2025.

BioVaxys Technology Corp. has received a management cease trade order (MCTO) from the British Columbia Securities Commission due to delays in filing its audited annual financial statements.

BioVaxys Technology Corp. will present at the Emerging Growth Conference on January 16, 2025, offering investors and analysts a real-time interactive session with the company’s leadership.